Get startedLog in
    Picture of CNS Pharmaceuticals logo

    CNSP — CNS Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: CNS Receives U.S. FDA Approval For Protocol Amendment To Trial Evaluating Berubicin

    Picture of CNS Pharmaceuticals logoCNS Pharmaceuticals
    23/06/2022 13:50
    June 23 (Reuters) - CNS Pharmaceuticals Inc  CNSP.O :
    * CNS PHARMACEUTICALS RECEIVES APPROVAL FROM U.S. FDA FOR
PROTOCOL
AMENDMENT TO ONGOING POTENTIALLY PIVOTAL GLOBAL TRIAL EVALUATING
BERUBICIN FOR THE TREATMENT OF GBM

Source text for Eikon:  ID:nPn5PbmNPa 
Further company coverage:  CNSP.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on CNS Pharmaceuticals

    See all news